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Abstract
Shigella, the causative agent of bacillary dysentery, invades epithelial cells by locally reorganizing the actin cytoskeleton.
Shigella invasion requires actin polymerization dependent on the Src tyrosine kinase and a functional bacterial type III
secretion (T3S) apparatus. Using dynamic as well as immunofluorescence microscopy, we show that the T3S translocon
component IpaC allows the recruitment of the Src kinase required for actin polymerization at bacterial entry sites during the
initial stages of Shigella entry. Src recruitment occurred at bacterial-cell contact sites independent of actin polymerization at
the onset of the invasive process and was still observed in Shigella strains mutated for translocated T3S effectors of invasion.
A Shigella strain with a polar mutation that expressed low levels of the translocator components IpaB and IpaC was fully
proficient for Src recruitment and bacterial invasion. In contrast, a Shigella strain mutated in the IpaC carboxyterminal
effector domain that was proficient for T3S effector translocation did not induce Src recruitment. Consistent with a direct
role for IpaC in Src activation, cell incubation with the IpaC last 72 carboxyterminal residues fused to the Iota toxin Ia (IaC)
component that translocates into the cell cytosol upon binding to the Ib component led to Src-dependent ruffle formation.
Strikingly, IaC also induced actin structures resembling bacterial entry foci that were enriched in activated Src and were
inhibited by the Src inhibitor PP2. These results indicate that the IpaC effector domain determines Src-dependent actin
polymerization and ruffle formation during bacterial invasion.
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Introduction
Shigella, the causative agent of bacillary dysentery, uses a T3S
apparatus to invade epithelial cells [1,2]. Actin reorganization
during Shigella entry involves Rho GTPases as well as the
activation of the Src tyrosine kinase [3,4]. Using fibroblastic cells
derived from Abl knock-out mice, it was shown that Abl-Crk
signaling is implicated in the activation of Rac [5], suggesting that
Abl activation by Src may act upstream of RhoGTPases. Src
tyrosine kinase activity, however, also modulates actin polymer-
ization downstream of RhoGTPases. For example, cortactin, a
cytoskeletal protein that has been reported to activate the Arp2/3
complex and to induce actin polymerization, is tyrosyl phosphor-
ylated in a Src-dependent manner during Shigella entry into
epithelial cells [6–8]. In cells where Src activity is inhibited, actin
polymerization is limited to the intimate contact between the
bacteria and the host cell membrane, indicating that Src allows the
amplification of actin polymerization at Shigella entry sites required
for the formation of extensions that surround the bacterium [3,8].
Signaling through Src family kinases leading to actin polymeriza-
tion at the plasma membrane occurs under physiological
stimulation or in tumor cells during outside-in integrin receptor-
mediated signaling [9]. However, cytoskeletal remodelling depen-
dent on Src has been reported for viruses, bacteria and parasites,
suggesting that such signaling corresponds to a common theme
that controls actin dynamics at the membrane [9,10]. Bacterial
T3S systems, however, allow the targeting of bacterial pathogenic
effectors into the cell cytosol that may potentially bypass
membrane signaling [2,11]. These secretion devices share similar
structural and functional features and are widespread among
gram-negative pathogens. Upon cell contact, two T3S substrates
are secreted and insert into host cell membranes to form a so-
called ‘‘translocator’’ that allows the injection of other effectors in
the host cell cytosol. Consistently, the Shigella IpaB and IpaC
translocator components have the ability to form a pore into host
cell membranes with an estimated size of 2–3 nm, that
corresponds to the estimated inner diameter of the T3S needle
[12,13]. Pathogen-mediated reorganization of the host cell
cytoskeleton may occur through translocated effectors that target
RhoGTPases, as observed for Salmonella or Yersinia, or by inducing
tyrosine kinase signaling at the membrane in the case EPEC or
viruses such as vaccinia [10,11,14,15]. The nucleotide sequence of
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determined, providing an exhaustive view of T3S effectors [16,17].
Among constitutively expressed effectors, some have been
implicated in bacterial invasion. The IpaA protein binds to the
focal adhesion protein vinculin and induces actin depolymeriza-
tion, which is required for completion of the entry process [18].
The IpgD protein, that hydrolyses phosphatidylinositol (4,5)-
bisphosphate, contributes to the disruption of cortical actin
structures required for efficient bacterial uptake [19,20]. More
recently, IpgB1 was reported to act upstream of Rac by hijacking
the ELMO/Dock pathway [21,22]. IpgB2 was identified as a
RhoA mimick, but its implication in bacterial invasion has not
been investigated [23]. In addition to participating in T3S, IpaC,
through its carboxyterminal domain, was shown to induce actin
polymerization responsible for the formation of cell extensions that
engulf the bacterium [24–26]. While Shigella type III effectors may
act synergistically to induce bacterial invasion, only bacterial
mutants for T3S or for translocator components are totally
defective for cytoskeletal reorganization and bacterial entry. In this
report, we present evidence that the translocator component IpaC,
through its carboxyterminus, participates in early signaling events
by allowing the recruitment and activation of the Src tyrosine
kinase.
Results
Src is recruited early during Shigella invasion
To gain insights into the relationship between Src and bacterial
induced actin-polymerization, we analyzed the kinetics of Src
recruitment during the early phases of bacterial invasion. HeLa cells
were transfected with a Src-GFP construct, which was previously
shown to behave as endogenous Src [27]. Transfected cells were
challenged with Shigella while following Src-GFP recruitment and
bacterial-induced ruffles by time-lapse microscopy. We selected Src-
GFP transfected cells that showed moderate fluorescence levels, with
no obvious alterations in their morphology. As shown in Figure 1,
Src recruitment often occurred early at the intimate bacterial-cell
contact site (Figure 1, arrowheads; see Video S1). Following this
initial recruitment, Src was detected in extensions that formed in the
vicinity of the adhering bacteria. This pattern of Src recruitment,
with an initial recruitment at the intimate bacterial contact site, was
observed in the majority of foci analyzed (68%, 22 foci, n=3). In
other instances, however, Src-containing ruffles formed in a more
diffuse manner, without obvious correlation with an invading
bacterium and appeared to merge over the cell surface to form
large ruffles (Figure 1B, arrows). Anti-pY416, an antibody that
recognizes the active form of Src family kinases (Materials and
Methods) showed staining at Shigella actin foci, suggesting Src
activation at entry sites (Figure 1C, arrowheads). Following bacterial
invasion, however, Src was found recruited at the intimate bacterial
contact site inside host cells without detectable pY416 staining
(Figure 1C, arrows), suggesting that Src activation occurs transiently
at the levels of bacterial-induced entry foci. Consistently, Shigella
invasion induced a transient Src-dependent tyrosyl phosphorylation
of the cytoskeletal protein cortactin, correlating with actin foci
formation and peaking at 15 min that was strongly inhibited by the
Src inhibitor PP2 (Figure S1).
To determine whether other kinases could participate in Shigella-
induced actin polymerization, which could account for the
formation of entry foci with no detectable recruitment of Src, we
used SYF fibroblastic cells that are deficient for all three Src family
kinases, Src, Fyn and Yes [27]. When challenged with the Shigella
wild-type strain, SYF cells formed small actin foci that were not
detected when cells were challenged with the isogenic non-invasive
mxiD strain (Figure S2A and S2B), suggesting that other kinases
that do not belong to the Src family kinases could participate in
Shigella invasion. Transfection of Src-GFP in these cells, however,
resulted in an increase in the size of Shigella-induced actin foci, as
well as in a three-fold increase in the frequency of actin foci
formation (Figure S2A and S2B). In contrast, Fyn-GFP transfec-
tion did not result in any significant increase in foci formation
(Figure S2A and S2B). Furthermore, while Src-GFP recruitment
could be observed at the bacterial contact site in 73.0%66.6
(SEM) of the cells analyzed (100 cells, n=3), only 3.6%61.3
(SEM) showed Fyn-GFP recruitment at the bacterial contact site
(584 cells, n=3) (Figure S2C). Together, these data support a
major role for Src in Shigella-induced actin polymerization during
invasion, and suggest that PP2 – sensitive kinases other than Src
family kinases could also participate in Shigella invasion.
Early recruitment of Src at Shigella entry sites occurs
independently of actin polymerization
To analyze the localization of Src relative to polymerized actin,
dual fluorescent labeling was performed. In nascent entry sites, Src
was detected at the close bacterial-cell contacts (Figure 2A, top
panels). In more developed entry foci, while polymerized actin was
detected in bacterial-induced extensions, Src localized in an inner
region containing little F-actin in 67.2611.4% of foci (45 foci,
n=3), as illustrated in Figure 2A, arrowheads. In the remaining
foci, Src localized in extensions but not in strict association with
actin as shown in Figure 2A, bottom panels, suggesting that Src
recruitment could occur independently of actin polymerization.
To test this, cells were treated with the actin polymerization
inhibitor cytochalasin D prior to bacterial challenge. Control
experiments indicated that cell treatment with cytochalasin D for
30 min at a final concentration of 1 mg/ml led to the
disappearance of actin stress fibers, indicating efficient actin
inhibition (not shown). Such treatment followed by bacterial
challenge in the presence of cytochalasin D led to virtually total
inhibition of Shigella-induced actin polymerization ([28]; not
shown). Removal of cytochalasin D after cell treatment by
Author Summary
Type III secretion systems (T3SS) are present in a wide
range of Gram-negative bacteria that are pathogenic to
humans, animals, and plants. These molecular devices
allow the injection of bacterial virulence factors into host
cells to manipulate various cellular functions. T3SSs share
similar functional features. Noticeably, host cell contact
triggers the secretion of two T3SS substrates that insert
into host cell membranes to form a so-called ‘‘translocator’’
required for the injection of T3SS effectors. Shigella,a n
enteroinvasive pathogen responsible for bacillary dysen-
tery, uses a T3SS to transiently reorganize the actin
cytoskeleton and to induce its internalization into epithe-
lial cells. Some Shigella-injected T3SS effectors participate
in cytoskeletal reorganization, but none of these effectors
are totally necessary or sufficient to induce bacterial
invasion. We show here that in addition to its role in the
injection of bacterial effectors, the translocator component
IpaC also induces the recruitment of Src and actin
polymerization driving the formation of localized mem-
brane ruffling. Our findings suggest that major signaling
through T3S translocator components occurs during the
initial steps of bacterial interaction with host cell
membranes. Compounds that prevent membrane inser-
tion of the Shigella T3S translocator would likely constitute
ideal candidates for antimicrobial agents.
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Methods) however, allowed the detection of de novo polymerized
actin, which was visualized as distinct patches at the bacterial
vicinity (Figure 2B). These patches could clearly be distinguished
from Src recruitment at the intimate bacterial contact site
(Figure 2B). Very few bacterial-induced actin rich ruffles could
be observed and Src recruitment remained limited to the intimate
bacterial-cell contact sites (Figure 2B), suggesting that the
distribution of Src away from the attached bacteria required actin
polymerization.
To analyze the role of T3S in Src recruitment, we performed
immunofluorescent staining of the translocator component IpaC. As
shown in Figure 2C, IpaC staining localized with Src in areas where
little F-actin could be detected after 5 min of Shigella challenge at
37uC (Figure 2C, arrowheads). At these early stages of invasion,
however, bacterial-induced actin polymerization is not prominent,
makingitdifficulttoassesswhetherT3Sislinkedwithfociformation.
When samples were incubated for 15 min at 37uC, bacterial-
induced actin foci were clearly observed, but IpaC was only detected
in approximately 20% of these entry foci analyzed suggesting a
highly dynamic distribution of IpaC during foci formation. In all foci
analyzed, IpaC staining was detected in areas of the foci where Src
was enriched (39 foci, n=4), corresponding to an inner region of the
actin foci (Figure S3). When cells were treated with cytochalasin D,
Figure 1. Src is recruited and activated early at Shigella entry sites. (A,B) Represent two sequences of bacterial entry events of HeLa cells
transiently transfected with Src-GFP. The numbers correspond to the elapsed time from the addition of bacteria in seconds. Src-GFP is recruited early
at the intimate bacterial–contact site (arrowheads), followed by recruitment in bacterial-induced ruffles. The arrow points at large ruffles that occur at
bacterial entry sites without detectable prior recruitment at the intimate bacterial contact site. Scale bar=5 mm. (C) HeLa cells transfected with Src-
GFP (green) were challenged with bacteria for 15 min at 37uC and processed for immunofluorescent staining of F-actin (greyscale) and anti-PY416
(red). Shigella-induced Src activation occurs during bacterial invasion.
doi:10.1371/journal.ppat.1000271.g001
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was enriched (Figure 2D, dashed box).
Together, these results suggest that the early distribution of Src
at the bacterial intimate contact occurs independent of actin
polymerization, however the distribution of Src away from the
bacterial attachment site requires actin polymerization as this was
not observed in the presence of cytochalasin D.
T3S ‘early invasion’ injected effectors are dispensable for
Src recruitment and activation during Shigella invasion
To investigate the relationship between translocated T3S
effectors and Shigella-induced Src-signaling, we analyzed the
recruitment of Src in cells challenged with various Shigella strains.
As shown in Figure 3A, wild-type Shigella or an isogenic ipgB1
mutant strain induced Src recruitment at entry sites (Figure 3A, wt
and ipgB1). In the case of ipgB1, however, Src recruitment
remained at the close vicinity or the intimate bacterial-cell contact
and was not observed in membrane ruffles surrounding the bound
bacteria as wild-type Shigella. We extended this analysis to all other
Shigella translocated T3S effectors previously been implicated in
bacterial invasion. Shigella mutants for IpaA, IpgB2, and IpgD
were fully proficient at recruiting Src at bacterial entry sites (Figure
S4). In contrast, the translocator component mutants of IpaB or
IpaC failed to induce Src at bacterial contact sites (Figure 3A,
ipaC, Figure S4). As previously described, when anti-phosphotyr-
Figure 2. Differential pattern of Src and actin localization at Shigella entry sites. HeLa cells transfected with Src-GFP were challenged at
37uC with the wild-type strain M90T. (A,B) Reconstructions of deconvolved images from focal planes spaced by 0.2 mm. Samples were fixed and
processed for fluorescent staining with rhodamine-phalloidin (actin), anti-bacterial LPS (blue). GFP-fluorescence is shown in green. (A) Cells were
challenged with bacteria for 15 min. Src localizes in an inner region of foci, whereas F-actin labels bacterial-induced ruffles (arrowheads). (B) Cells
were treated with cytochalasin D at a final concentration of 1 mg/ml for 30 min and challenged with bacteria for 10 min in the absence of
cytochalasin D (Materials and Methods). Src-GFP is recruited at the bacterial-cell intimate contact, whereas Shigella-induced actin polymerization is
detected as individual patches juxtaposing the bacteria (arrowheads). (C,D) HeLa cells transfected with Src-GFP were challenged for 10 min at 37uC
with the ipaC/C1 strain. Samples were fixed and processed for fluorescent staining with rhodamine-phalloidin (red), and anti-IpaC pAb (blue). GFP-
fluorescence is shown in green. (C) Cells treated with cytochalasin D at a final concentration of 1 mg/ml for 30 min prior to bacterial challenge. Src,
actin, and IpaC: deconvolved images of a single focal plane; IpaC+phase: overlay of the IpaC panel with the corresponding focal plane acquired in
phase contrast (Materials and Methods). During early stages of bacterial invasion, IpaC is detected at bacterial-cell contact sites and colocalizes with
Src-GFP, in a region where little F-actin is detected. Scale bar=5 mm.
doi:10.1371/journal.ppat.1000271.g002
Src Activation by the Shigella IpaC Protein
PLoS Pathogens | www.plospathogens.org 4 January 2009 | Volume 5 | Issue 1 | e1000271osine Western-blot analysis was performed on cells challenged with
wild-type Shigella, a clear induction of protein tyrosylphosphoryla-
tion was observed that was not detected when cells were
challenged with the non-invasive isogenic derivative mxiD mutant
strain (Figure 3B) [3]. As shown in Figure 3B, the various Shigella
ipaA, ipgD, ipgB1 or ipgB2 mutant strains induced patterns of
tyrosine phosphorylation, in particular the Src-dependent phos-
phorylation of the 80 kDa cortactin protein, that were not
different than those induced by wild-type Shigella (Figure 3B,
arrows). Collectively, these results indicate that T3S translocated
effectors of invasion are dispensable for Src recruitment and
activation during Shigella invasion.
Effects of IpaC mutations on bacterial-induced hemolysis
and invasion
As bacterial mutants for T3S translocated effectors still induced
Src signaling, we then investigated whether the translocator
components could be involved in this process. In particular,
because IpaC had been previously involved in signaling leading to
actin polymerization, we analyzed the effects of IpaC on Src
activation induced by Shigella during entry. Biochemical and
structure-function studies of IpaC have provided insights about its
domain organization [26,29,30]. As depicted in Figure 4, IpaC
contains a large hydrophobic domain (residues 100–170) allowing
interaction with lipid membranes, and a carboxyterminal coiled-
coil domain (residues 330–357) that is involved in oligomerization
and in actin nucleation [26]. To differentiate between mutations in
IpaC that inhibit signaling but not T3S translocation, we
constructed a series of deletions and analyzed them for their
ability to complement an ipaC mutant for red blood cells
hemolysis, an assay previously used to test for T3S-induced pore
formation (Figure 4; [12]). As shown in Table 1, and as expected,
virtually no hemolysis was observed for the T3S-defective mxiD
mutant, while the ipaC mutant showed decreased hemolytic
activity of 16.5% efficiency. Complementation of the ipaC mutant
with full length IpaC restored hemolytic activity to levels
comparable to those induced by wild-type Shigella. In contrast,
the ipaC internal deletions CD122–300, CD56–143, CD300–363,
CD187–363 or removal of the last five or ten carboxy-terminal
residues in CD359–363 and D354–363, respectively, strongly
reduced bacterial-induced hemolysis (Table 1). Deletion in
CD346–350 had little effects on hemolysis or actin foci formation.
Interestingly, while in general, deletions had drastic effects on
hemolysis, insertion of an eleven-residue epitope at position 300
(C300) only partly reduced hemolysis, while insertions at positions
57 (C57) or 351 (C351) of a C3 epitope, or of a Myc-epitope C-
Figure 3. Shigella T3S translocated IpgB1 effector is not required for Src recruitment and activation. (A) HeLa cells were transfected with
Src-GFP and challenged at 37uC for 15 min. with wild-type Shigella, the ipaC, or the ipgB1 mutant strains. Samples were fixed and processed for anti-
LPS immunofluorescence labelling (blue), and F-actin staining (red). GFP fluorescence is shown in green. The panel corresponds to reconstructions of
deconvolved images from focal planes spaced by 0.2 mm. Unlike the ipaC mutant, the wild-type and ipgB1 mutant induces Src recruitment at
bacterial entry sites. (B) HeLa cells were challenged with the indicated Shigella strains, and at various time intervals samples were lysed and processed
for anti-phosphotyrosine Western-blot analysis (Materials and Methods). The time is indicated above each lane in min. The Shigella mutant strains
deficient for the translocated T3S effectors ipaA, ipgD, ipgB1, and ipgB2 induce phosphotyrosine patterns that are similar to that induced by wild-type,
whereas the ipaC mutant is defective at inducing tyrosine phosphorylation. The arrows indicate the expected migration of tyrosylphosphorylated
cortactin.
doi:10.1371/journal.ppat.1000271.g003
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activity (Table 1). In spite of these high levels of hemolytic activity,
C300 and C351 showed a strong defect in bacterial invasion, with
levels that were not different than those observed in an ipaC
mutant (Table 1). Together, these data support the notion that the
last 63 carboxyterminal residues are involved in signaling leading
to actin remodeling and bacterial invasion.
Shigella invasion does not require high levels of T3S
substrates translocation
To investigate what were the limiting levels of translocated T3S
effectors for bacterial invasion, we performed translocation assays
in HeLa cells. Experiments were conducted with strain SF126, a
Shigella mutant strain that expresses reduced levels of Ipa proteins
but that still efficiently invades epithelial cells [31]. Briefly,
following bacterial challenge, samples were lysed in 0.1% Triton,
under conditions that do not induce bacterial lysis. After
elimination of intact bacteria by centrifugation, cell lysates were
subjected to anti-IpaB, or -IpaC immuno-precipitation and
immunoprecipitates were analyzed by Western-blotting. As shown
in Figure 5, in the ipaC mutant complemented with wild-type
IpaC, secretion of IpaB and IpaC in host cell membranes could be
readily detected (Figure 5, C1). As expected, no translocation
could be detected for the T3S-deficient mxiD mutant (Figure 5,
mxiD). As shown in Figure 5 and in line with their respective levels
of expression, the SF126 strain showed levels of translocation of
IpaB and IpgD that were strongly reduced compared to ipaC/pC1
(Figure 5, Transloc). In spite of these low levels of T3S
translocation, however, and consistent with previous reports,
SF126 was as efficient as wild-type Shigella in inducing actin foci
formation (Figure 6) [31]. Furthermore, actin polymerization and
Src recruitment at entry sites induced by SF126 were not different
than those induced by wild-type Shigella (Figure S4). These results
indicate that only a minor fraction of translocated T3S substrates
is required for bacterial invasion.
The C351 insertion impairs signaling, leading to actin
reorganization and bacterial invasion
We then investigated whether impairment of bacterial
invasion for the ipaC/pC351 was linked to a defect in the
translocation of T3S substrate. As shown in Figure 5, although
ipaC/pC351 showed levels of translocation that were reduced
compared to those occurring in the ipaC/pC1 strain expressing
wild-type IpaC (Figure 5, Transloc, compare C351 and C1),
translocated IpaB and IpaC351 were clearly detected when
compared to the T3S-deficient mxiD strain (Figure 5, Transloc).
IpaB and IpgD were translocated at levels that were even higher
in the ipaC/pC351 strain than in the invasive proficient strain
SF126 (Figure 5, Transloc). Consistent with its inability to induce
signaling required for actin reorganization, anti-phosphotyrosine
Western-blot analysis performed on lysates of cells infected with
the various ipaC complemented strains indicated that ipaC/C351
was as deficient as the ipaC or mxiD mutants at inducing Src-
dependent cortactin phosphorylation (Figure 6A) and at inducing
Figure 4. Scheme of IpaC derivatives. Domain organization of IpaC. Solid black box: secretion signal sequence; checked box: chaperone binding
region; empty box: hydrophobic predicted transmembrane domain; hatched box: coiled-coil region; dotted-box: region involved in actin
polymerization and bacterial invasion. The name of IpaC derivatives is indicated on the left. The solid triangles represent the insertion of an 11-
residue epitope from phage C3 within the ipaC coding sequence [29]; the position of the residue corresponding to the insertion site is indicated.
Deletions corresponding to the indicated residues are represented by a dotted line. The myc epitope insertion at the carboxyterminal end is
represented by a grey box with horizontal lines.
doi:10.1371/journal.ppat.1000271.g004
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as efficient as wild-type, ipaC/pC351 was as deficient as the ipaC
or mxiD mutants to induce actin foci formation. These results
indicate that the C351 insertion does not affect the translocation
of T3S effectors to levels that are detrimental for Shigella
invasion. Similar results to C351 were obtained with the C1myc
construct (data not shown). Both ipaC/pC351 and ipaC/pC1myc
strains were deficient at inducing actin foci and at recruiting Src
(Table 1 and Figure S5).
Together, these results support a direct role for the carbox-
yterminal domain of IpaC in signaling leading to bacterial uptake.
The actin polymerization inhibitor Latrunculin B inhibits
the translocation of Shigella type III effectors
Because the C351 insertion that impaired Shigella-induced actin
polymerization led to reduced translocation, we investigated
whether actin polymerization was required for efficient T3S
translocation. Cells were treated with latrunculin to inhibit
bacterial induced actin polymerization and the levels of translo-
cated effectors were determined. As shown in Figure 5, latrunculin
treatment significantly reduced translocation of IpaB and IpaC in
the Shigella ipaC/pC1 strain, down to levels that were comparable
to those observed in ipaC/pC351. In control experiments,
latrunculin treatment had no effects on IpaB and IpaC expression
levels or their in vitro secretion (Figure 5). To determine the effects
of latrunculin on the translocation of injected effectors, we
constructed a T3S reporter IpaA derivative, in which the
carboxyterminal IpaA-vinculin binding region was replaced by a
triple-FLAG epitope (A3F1) that we expressed in wild-type Shigella,
the ipaC/pC1, or the ipaC/pC351 strains (Materials and Methods).
As shown in Figure 7A, translocated A3F1 could clearly be
detected in cells challenged wild-type Shigella/pA3F1 or in ipaC/
pC1 pA3F1. In contrast, A3F1 showed decreased levels of
translocation in ipaC/pC351 pA3F1 (Figure 7A). As observed for
IpaB and IpaC, latrunculin treatment decreased A3F1 transloca-
tion for ipaC/pC1 pA3F1 to similar levels as observed for ipaC/
C351. These findings were confirmed by anti-FLAG immunoflu-
orescence staining of A3F1. When cells were challenged with wild-
type Shigella/A3F1, A3F1 staining could be visualized throughout
actin foci. Latrunculin treatment, however, inhibited actin
polymerization and limited A3F1 to discrete spots contacting the
bacteria (Figure 7B).
These results indicate that actin polymerization during bacterial
invasion is required for efficient T3S translocation. Taken together
with data from the previous section, these results suggest that the
C351 insertion in the IpaC carboxyterminal effector domain
impairs the translocation of T3S effectors because it interferes with
IpaC-mediated actin polymerization.
Table 1. Effects of ipaC mutations on Shigella-induced contact hemolysis.
Strain Secretion
a Relative % Hemolysis
b Actin Foci/Cell
c % Bacterial Invasion
d
M90T + 96.063.2 1.2 100
mxiD 2 5.060.3 0.0 0.0960.02
ipaC 2 16.565.7 0.0 0.2160.08
ipaC/pC1 + 93.066.7 0.4 47.761.56
ipaC/pCD1–100 2 ND ND ND
ipaC/pCD122–300 + 3.360.7 0 ND
ipaC/pCD56–143 + 4.360.5 0 ND
ipaC/pCD300–363 + 12.164.1 0 ND
ipaC/pCD187–363 + 8.261.4 0 ND
ipaC/pC57 + 95.565.0 1.1 3469.80
ipaC/pC187 + 95 0.3 20.5560.15
ipaC/pC267 + 95 0.4 26.2563.88
ipaC/pC300 + 49.263.7 0.1 0.2560.05
ipaC/pC351 + 88.762.2 0.0 0.2560.04
ipaC/pC1myc + 70.765.7 0 ND
ipaC/pCD346–350 + 90 1.2 ND
ipaC/pCD359–363 + 12 0 ND
ipaC/pCD354–363 + 12 0 ND
aBacterial strains were grown to mid-exponential phase in the presence of Congo Red, and ipaC transformants were induced with IPTG to allow the expression and the
secretion of the various IpaC constructs (Materials and Methods). Secretion was determined by analyzing the presence of the IpaC derivative in the bacterial culture
supernatant by anti-IpaC Western-blot analysis. 2 : no detectable IpaC in the bacterial culture supernatant; + : detection of the IpaC derivative. No significant variation
in the efficiency of secretion could be observed between the various constructs (not shown), with the exception of the CD1–100 construct that does not show
significant levels of secretion.
bHorse blood erythrocytes were challenged with the various bacterial strains, and the extent of hemolysis was quantitated by reading the absorbance at 595 nm
(Materials and Methods). The relative percentage of hemolysis corresponds to the ratio of the hemolysis determined for the sample over that of total hemolysis,
determined for samples treated with 0.1% SDS. The values correspond to the mean of three independent experiments performed in triplicates. The ipaC mutant strain
shows residual hemolytic activity that was previously shown to depend on IpaB [12]. The ipaC transformants expressing the C57, C351, or C1myc derivatives show a
hemolytic activity that is comparable to that conferred by full-length IpaC.
cHeLa cells were challenged with bacterial strains for 15 min. at 37uC. Samples were fixed and processed for fluorescent staining of F-actin and bacterial LPS. Bacterial
induced actin foci were scored microscopically, and the numbers were normalized to the number of cells analyzed. The values are representative of at least 40 cells
analyzed in a representative experiment.
dBacterial internalization was measured using the gentamicin assay. The values correspond to representative experiments performed in triplicates.
doi:10.1371/journal.ppat.1000271.t001
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dependent actin polymerization
We next wanted to determine whether the IpaC effector
domain alone was sufficient to induce Src activation and actin
polymerization. In previous studies, using a cell permeabilization
assay, IpaC was shown to induce actin polymerization and
filopodial structures [24]. This assay, however, did not allow us
to study Src activation as the permeabilization procedure by
itself induced changes in the pattern of tyrosyl phosphorylation
(Mounier, unpublished data). We therefore sought a system that
does not involve cell permeabilization and that, unlike cell
transfection, would allow us to study short-term effects on
cytoskeletal reorganization mediated by the translocation of the
IpaC effector domain at the cell membrane. To do this, we used
the Iota two-component toxin as a delivery system [32]. The
IpaC carboxyterminal residues 291–363 containing the oligo-
merization and effector domain were coupled to the residues 41–
454 of the Iota Ia component. A glutamic acid was substituted
for an alanine residue at Iota Ia position 380 to abolish its ADP-
ribosyl transferase activity to generate the IaC peptide
(Figure 8A; [32]). This construct was expressed and purified as
a His-tagged fusion recombinant protein (Materials and
Methods). Cells were incubated with the Ib and IaC components
for 15 min at 21uC, followed by 15 min at 37uC (Materials and
Methods). Samples were fixed and processed for fluorescence
staining of F-actin. As shown in Figure 8B, control cells treated
with IbIa showed a defined cortical actin periphery with
prominent stress fibers (Figure 8B, IbIa). In contrast, incubation
with IbIaC led to disappearance of stress fibers and the
formation of actin-rich microspikes at the cell periphery
(Figure 8B, IbIaC). Strikingly, in a few instances, actin-rich
structures that resembled bacterial-induced entry foci could also
be observed on the apical surface of IbIaC treated cells
(Figure 8B, arrows and bottom panels). Like bacterial entry foci,
these structures were raised several microns above the cell
surface and consisted of actin-rich membrane leaflets that appear
to emanate from a discrete area (Figure 8B). When quantified,
17. 061.0% of IbIaC-treated cells showed these actin foci. In
contrast, no such actin structures were detected when cells were
treated with Ib and Ia alone (300 cells, n=3), or with Ib and
IaC351, which corresponds to recombinant Ia fused to the IpaC
carboxyterminal residues 291–363 containing the C351 insertion
(395 cells, n=3) (Materials and Methods, Figure S6). To detect
the IbIaC complex, Ib was fluorescently labeled using as
previously described [33]. Fluorescent Ib showed a staining
reminiscent of intracellular endosomes consistent with previous
studies using this delivery system (not shown and [33]). However,
when cells were incubated with fluorescent Ib associated with
IaC, staining could also be detected at the levels of actin-like foci
enriched in Src-GFP (Figure S7, arrows). To determine the role
of Src in actin structures induced by IaC, cells transfected with
Src-GFP were treated with IbIaC and processed for immuno-
fluorescence staining of F-actin and with anti-pY416. As shown
in Figure 8A, in transfected cells, IbIaC induced the formation of
large ruffles enriched in Src-GFP and F-actin (Figure 9A,
arrows). In addition to these ruffles, IbIaC also induced actin foci
that contained Src-GFP (Figure 9B). These IbIaC-induced
structures were also enriched in activated Src as indicated by
staining with the anti-pY416 antibody (Figure 9A) and cortactin
(Figure 9B). In contrast, and as expected, Src-GFP transfected
cells challenged with IbIa showed fewer ruffles, with 6.662.1%,
compared to 49.6615.9% of IbIaC treated cells with ruffles
(Figure 9A and 9C). When treated with PP2, a significant
inhibition of ruffles formation was observed following IbIaC
stimulation, with only 1364.3% of the cells displaying ruffles
(Figure 9C). Taken together, these results indicate that the
effector domain of IpaC is sufficient to induce Src-dependent
actin ruffles.
Discussion
We show here that Src is recruited at the intimate contact site
between Shigella and the host cell membrane during the early
steps of invasion. Shortly after this intimate recruitment,
however, Src was observed in extensions surrounding the
bacteria, and cells pre-treated with cytochalasin had no Src
accumulation in these extensions. This suggests that Src
activation occurs at the intimate bacterial-contact site and that
Src rapidly diffuses from this sitei na na c t i n - d e p e n d e n tm a n n e r .
This is reminiscent of a report in which Src activation was
followed in real time using a fluorescence resonance energy
transfer probe and anti-integrin coated beads as a means to
trigger local Src activation [34]. It was observed that following
Src activation at the site of bead-membrane contact, Src
activation rapidly diffused from the initial site of activation in an
actin-dependent manner and filopodial extensions formed at the
Figure 5. The C351 insertion in the IpaC effector domain does
not prevent T3S translocation. Bacterial strains were grown to
exponential phase, and T3S was induced by the addition of Congo Red
in the culture medium. Bacterial lysates (Lysate) or supernatants
(CRsupe) were analyzed by anti-IpaB and anti-IpaC Western blot
analysis. HeLa cells were challenged with the various bacterial strains for
30 min at 37uC. Translocated T3S effectors were subjected to immuno-
precipitation and analyzed by Western-blot analysis (Transloc, Materials
and Methods) or by anti-actin Western-blot analysis (actin). The
corresponding T3S effectors are indicated on the right. Cells challenged
with: C1: ipaC/pC1; C1+lat: ipaC/pC1 after latrunculin treatment; mxiD:
the non-invasive mxiD strain; C351: ipaC/pC351; SF126: a polar insertion
upstream of the ipa locus that leads to decreased expression of Ipa
proteins [31].
doi:10.1371/journal.ppat.1000271.g005
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reports, we showed that Src inhibition did not prevent actin
polymerization at the intimate bacterial-cell contact, but that
the Src-dependent cortactin phosphorylation was required to
amplify actin polymerization at extensions surrounding the
invading microorganism [3,8]. Thus, actin polymerization that
leads to bacterial-induced ruffling appears to require Src
activation, but Src also needs actin polymerization to localize
properly in ruffles that surround the bacteria. Such a dual
requirement for Src and actin has been reported in processes
controlling cell adhesion dynamics and Src activation [27,35].
Consistent with a role for IpaC in Src recruitment and
activation, IpaC often co-localized with Src at entry sites, although
in many instances, Src could be detected at entry sites in the
absence of IpaC. This could reflect the rapid dynamics of Src
diffusion, as discussed above, or alternatively, could correspond to
removal of IpaC from entry structures linked to its degradation, as
shown for the Salmonella T3S effector SopE [36]. The IpaC effector
domain localised to the last 63 C-terminal aminoacids of the
protein, was also reported to direct actin nucleation in vitro [26]. In
this study, IpaC rarely co-localized with F-actin, contradicting the
notion that it acts simply as an actin nucleator. Also, the fact that
the ipaC/C1 strain that secretes larger amounts of IpaC but
induces actin foci of smaller size than wild-type Shigella argues
against a simple direct role of IpaC in actin nucleation. Rather,
these results indicate that a proper balance of IpaC-mediated
signaling determines optimal actin polymerization.
We show that Shigella T3S is dramatically enhanced by actin
polymerization, given that latrunculin treatment significantly
reduced the translocation of T3S effectors. A role for actin in
T3S has also been observed as Yersinia T3S-dependent pore
formation is sensitive to actin inhibitors [37]. Since the Rho but
not the Rac GTPase was found to be required for the translocation
of Yop proteins, it was speculated that actin polymerization
mediated by formins downstream of Rho was important for T3S-
mediated injection of effectors [38]. One possibility is that
following the initial bacterial-cell contact and a primary injection
of T3S effectors, actin polymerization allows the formation of cell
extensions that favors further contact between the plasma cell
membranes and T3S apparatus, thus increasing T3S. Consistent
with this hypothesis, real time analysis of Shigella invasion indicates
that the initial contact between bacteria and the host cell
implicates only a limited area at the bacterial surface, often at
one bacterial pole, while bacterial engulfment involves the
formation of membrane ruffles along the bacterial sides ([39];
Video S2).
To follow effects linked to translocation of the IpaC carbox-
yterminal effector domain into the cell cytosol, we used the C.
Figure 6. The C351 insertion in the IpaC effector domain impairs Src-dependent signaling. (A) HeLa cells were challenged for 15 min at
37uC with the bacterial strain indicated above each lane. Cell lysates were subjected to anti-phosphotyrosine (top panel) or anti-cortactin (bottom
panel) Western blot analysis. The molecular weight markers are indicated. The arrows point at cortactin. As oppposed to C57, C351 do not
complement the ipaC mutant strain for induction of the phosphorylation of cortactin. (B) HeLa cells were challenged for 15 min at 37uC with bacteria.
Samples were fixed and processed for fluorescent staining with rhodamine-phalloidin (green) and anti-bacterial LPS (red). Arrows indicate actin foci.
Scale bar=10 mm. (C), Actin foci were scored microscopically on at least 4 independent experiments (n.200). Cells challenged with the indicated
strains, or with the ipaC mutant complemented with C1, C57, or C351. SF126 harbours a polar insertion upstream of the ipa locus that leads to
decreased expression of Ipa proteins [31]. Expression of the C57 construct allows the ipaC mutant to induce actin foci at the same frequency as the
wild-type strain, whereas expression of full length IpaC leads to actin foci that are smaller and less numerous than those observed with wild-type
Shigella. Very few actin foci could be observed for the ipaC mutant strain expressing the C351 insertion.
doi:10.1371/journal.ppat.1000271.g006
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related anthrax toxin has been previously used as intracellular
delivery systems [32,40,41]. Iota belongs to the ADP-ribosylating
family of toxins, sharing the same transport mechanism as the
anthrax toxin [42]. Following association with the binding
component and cellular internalization, the enzymic component
is presumed to translocate into the cell cytosol through the pore
formed by the heptameric binding component [42]. The small 2–
3 nm diameter pore suggests that the enzymic component needs to
unfold to translocate [42,43]. The Shigella T3SS needle is thought
to have an internal diameter of 2–3 nm, and it is also believed that
IpaC needs to unfold to transit through the needle. Thus, it is
possible that this type of delivery system involves few structural
constraints and could be used with other T3S effectors. Consistent
with translocation occurring early after endocysosis at the levels of
early endosomes [44], this system allowed the visualization of Src-
dependent ruffles induced by the IaC fusion within minutes
following addition to cells. Strikingly, cell delivery of IaC also led
to the occasional formation of discrete actin structures resembling
bacterial entry foci, showing recruitment of active Src. These
structures are virtually never found in unstimulated HeLa cells,
suggesting that the use of the Iota delivery system to translocate
the IpaC effector domain presents similarities with T3S-mediated
translocation. Among these similarities, cell stimulation by IaC
presumably occurs at the levels of host membranes in a
synchronous manner. In the case of invading bacteria, however,
cytoskeletal reorganization is linked to the rapid and localized
injection of T3S effectors [39,45,46]. It is possible that these are
limiting factors in the case of Iota-mediated IaC translocation that
restrict the frequency of actin foci formation. Also, Shigella-mediated
ruffles may implicate other T3S effectors such as IpgB1 that favors
actin foci formation around invading bacteria [21,22]. Why does
IaC induce the formation of actin foci, even though its localization is
not restricted to these foci? The reason for this is unclear, however
one possibility is that some sub-cellular areas are more proficient at
inducing actin foci because they are enriched in a particular
component associated with the plasma membrane, required for
localized ruffles. Thus IaC endocytosed at these ‘‘proficient’’ areas
would trigger the formation of actin foci, while endocytosis in other
areas would be non-productive. When performing live imaging of
Shigella T3S during cell challenge, we observed that bacterial-
induced actin foci formation implicated at least one bacteria
triggering T3S at the corresponding site [46]. Consistent with cell
surface heterogeneity in its ability to form actin foci, bacterial
injection of T3S effectors was not systematically accompanied by
actin reorganization (our unpublished results).
Phosphorylation provides a means to insure the regulation of
transient events by regulating intra- and inter-molecular associa-
tion. [47–49]. Src phosphorylation also controls the scaffolding of
macromolecular complexes involved in cell adhesion or motility
whose function may depend on the intensity or the nature of the
stimuli. Deciphering the precise mechanism involved in IpaC-
mediated activation of Src will provide insights into mechanisms
controlling actin dynamics at the membrane.
Figure 7. Cell treatment with the actin polymerization inhibitor Latrunculin B leads to decreased T3S translocation. (A) HeLa cells
were challenged with A3F1-expressing bacteria for 30 min at 37uC, and translocated A3F1 was subjected to anti-IpaA immunoprecipitation and
analysed by anti-FLAG Western-blot analysis (Transloc). In control experiments, total lysates corresponding to bacteria-infected cells were analyzed by
anti-FLAG Western blot (Lysates). A3F1: bacteria expressing the A3F1 construct. WT: wild type Shigella; ipaC/C1: ipaC mutant complemented with full
length IpaC; mxiD: a T3S defective isogenic mutant; ipaC/C351: ipaC mutant expressing C351. The arrows point at the A3F1 construct. (B) HeLa cells
were challenged with wild-type Shigella expressing A3F1 for 15 min at 37uC in the absence (A3F1) or presence of latrunculin A (A3F1+Latrunc).
Samples were fixed and processed for immunofluorescence staining of bacterial LPS (bacteria), FLAG epitope (Flag), and actin (actin). FB: bacteria are
in green and the FLAG staining is in red. The panels represent reconstructions of deconvolved images from focal planes spaced by 0.2 mm. The insets
in the right panels are shown. Scale bar=5 mm. Translocation of A3F1 is reduced upon latrunculin treatment.
doi:10.1371/journal.ppat.1000271.g007
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Antibodies and reagents
The 4G10 anti-phosphotyrosine monoclonal antibody was from
Upstate Biotechnology Inc, (Lake Placid, NY). Horse blood was
obtained from Biome ´rieux (Marcy l’Etoile, France).
Rabbit polyclonal sera against S. flexneri L P So rI p a Cw e r e
described previously [50]. The anti-Src monoclonal antibody clone
327waspurchasedfromOncogeneScience(Uniondale,NY),andthe
anti-Src polyclonal antibody N16 was from Santa Cruz Biotechnol-
ogy. Anti-rabbit antibody coupled to CY3 was from Jackson
ImmunoResearch and anti-mouse coupled to Alexa Fluor 488 or
2380 were from Molecular Probes. The anti-FLAG M2 mAb,
Phalloı ¨din coupled FITC was from Sigma corp. (St-Louis, MO).
Bacterial strains, growth conditions, and cell lines
M90T was used as a wild-type invasive strain of Shigella flexneri
serotype 5. Shigella mxiD is a non-invasive mutant of M90T in
which the mxiD gene has been inactivated and which is deficient
for cell contact-dependent secretion. An ipaC mutant strain was
used for complementation by plasmids producing IpaC-C3
recombinant proteins. The recombinant proteins were constructed
by inserting the C3 epitope-coding sequence in the gene ipaC
carried by plasmid pC1 [29]. Strain SF126 has an insertion in icsB,
that shows a polar effect on the downstream ipa genes and lead to a
reduction in Ipa proteins expression without detectable effect on
bacterial invasion [31]. Bacterial strains were grown in trypticase
soy broth at 37uC with agitation. For invasion assay, overnight
cultures were diluted 100-fold and grown at exponential phase
(0D600 nm=0.3). Bacteria were washed in PBS and resuspended in
DMEM (Dulbecco Modified Earl’s Medium 1 g/l glucose) (Gibco
BRL) containing 50 mM HEPES (N-(2-Hydroxyethyl)piperazine-
N9-(2-ethanesulfonic acid) pH 7.4 (Sigma corp.). HeLa cells
(ATCC # CCL, 2), an epithelial cell line from human cervical
carcinoma, were grown at 37uC, 10% CO2 in DMEM
supplemented with 10% fetal calf serum.
Plasmid constructions
The pC1 plasmid containing the cloned ipaC gene, as well as the
C3-containing insertions were described previously [51]. The
plasmid containing internal truncations of ipaC, constructs
pCD56–143 and CD122–300, were generated from pC1 after
Figure 8. The IpaC last 72 carboxyterminal residues fused to the Iota Ia component induces actin foci-like structures. (A), Schematic
construction of IaC. Ia, the Iota Ia component. Solid box: signal sequence. Hatched box: enzymatic domain. IaC, the carboxyterminal residues 291–363
of IpaC containing the effector domain were fused to Ia*, corresponding to residues 41–454 of Ia with the E380A substitution that inactivates its
enzymatic function [32]. (B) HeLa cells were challenged with the Iota Ib component and Ia* (IbIa) or IaC (IbIaC and bottom panels) and processed for
fluorescent staining of F-actin. Arrows point at IbIaC-induced actin ruffles. Bottom panels: two series of focal planes corresponding to IbaC-induced
actin foci. The numbers indicate the distance in mm from the cell basal surface.
doi:10.1371/journal.ppat.1000271.g008
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filling and religating. The amino-terminal deletion CD1-100 was
generated by amplifying ipaC using the 59-forward primer 59-
GAGC CAT ATG CCA GAG AAC ACT CTG GAT-39 and the
reverse primer 59-GCGA GGA TCC TTA AGC TCG AAT
GTT ACC-39: the PCR fragment was digested with NdeI and
BamHI and cloned in the corresponding sites of pET19b
(invitrogen). The carboxy-terminal deletions CD187–363 and
CD300–363 were generated by digesting pC1 with NsiI or AflII,
respectively, end filling and religating. The C1-myc construct was
obtained amplifying and cloning the ipaC ORF including an
upstream Shine Dalgarno sequence into the NheI and XbaI sites of the
pBAD18 vector using the primers 59-ATATGCTAGCAAGGA-
GATATACATATGGAAATTCAAAACACAAAACC- 39 and
59-CGCTCTAGAAGCTCGAATGTTACCAGCAAT-39. Sub-
sequently, a phosphorylated oligonucleotide duplex encoding the
myc sequence was inserted in frame into the XbaI and HindIII
sites (59primer: CTAGAGAACAGAAACTGATTAGCGAA-
GAAGATCTGTAAA; 39primer: AGCTTTTACAGATCTTC
TTCGCTAATCAGTTTCTGTTCT). The A3F1 construct was
obtained by digesting plasmid pBad:IpaA [52] by PvuII and KpnI
to remove the last 39-end 85 nucleotides of ipaA that encodes the
major IpaA vinculin binding site [53,54]. The following primers 59
–TGGATTATAAAGATGACGATGACAAGGATTATAAAGA
TGACGATGACAAGGATTATAAAGATGACGATGACAAG-
TAACTGCATAAGGTAC – 39 and 59-CTTATGCAGTT
Figure 9. IaC-induced actin structures are enriched in Src. HeLa cells transfected with Src-GFP were challenged with the Iota Ib component
and Ia* (IbIa) or Ic (IbIaC) and processed for immunofluorescence staining of F-actin and PY416 (A) or cortactin (B). Arrows point at IbIaC-induced
actin ruffles that contain activated Src. Actin foci detected in IbIc-stimulated cells are enriched in Src-GFP and cortactin (arrows). Scale bar, 5 mm. (C)
Cells were challenged with IbIaC, IbIa, or IbIaC in the presence of 10 mM PP2. Src-GFP transfectants showing ruffles were scored microscopically. The
numbers are representative of at least 300 transfected cells in three independent experiments.
doi:10.1371/journal.ppat.1000271.g009
Src Activation by the Shigella IpaC Protein
PLoS Pathogens | www.plospathogens.org 12 January 2009 | Volume 5 | Issue 1 | e1000271ACTTGTCATCGTCATCTTTATAATCCTTGTCATCGTC
ATCTTTATAATCCTTGTCATCGTCATCTTTATAATCC
A-39 were annealed, filled in, digested with PvuII and KpnI and the
DNA fragment was cloned into the corresponding sites of
pBad18:IpaA [51] to generate the A3F1 construct fused to a
triple-FLAG epitope. A3F1 was excised from pBad:IpaA using
EcoRI and KpnI and subcloned into the corresponding sites of
pSU18 that is compatible with pUC-based plasmids to generate
pSU:A3F1. To construct the IaC fusion, the SalI-XhoI fragment of
plasmid pMRP516 containing the DNA insert encoding the C3
exoenzyme was exchanged for a 216 bp PCR product encoding
the IpaC residues [291–363] using the 59-TTTTGTCGAC-
TATCCACATCAGGAGGG-39 and 59-GCGACTCGAGTTA-
AGCTCGAATGTTAC-39 primers. The IaC351 fusion was
constructed using the same strategy and primers but using the
pC351plasmid as a matrix for PCR amplification. All clones were
verified by DNA sequencing.
Bacterial invasion and anti-phosphotyrosine immunoblot
Bacteria were grown at OD600=1, and freshly coated with
poly-L-lysine before challenge to facilitate bacterial adhesion to
cells. Bacteria were washed with PBS and resuspended with poly-
L-lysine (Sigma corp.) at a final concentration of 10 mg/ml. After
10 min incubation at room temperature, bacteria were washed 3
times with PBS, resuspended in DMEM containing 50 mM
HEPES pH 7.4, and used immediately. HeLa cells were plated the
day before at semi-confluency (5610
5 cells/35-mm diameter
culture dish), were washed twice with PBS containing 1 mM
sodium orthovanadate and challenged with the bacterial suspen-
sion for 20 minutes at room temperature to allow bacterial
attachment, and incubated for 15 min at 37uC. Samples were
transferred on ice, washed twice in ice-cold PBS containing
sodium orthovanadate and scraped with a rubber-policeman in
100 ml of Laemmli loading sample buffer. Samples were loaded
onto SDS-PAGE gels, and analyzed by anti-phosphotyrosine
Western blot. Filters were processed with ECL detection kit
(Amersham corp.). When indicated, cells were treated with 10 mM
PP2 for 30 min at 37uC in DMEM containing 50 mM HEPES
pH 7.4, and challenged with bacteria in the same buffer.
Contact hemolysis
Contact hemolysis analysis was performed as described
previously [12] with some modifications. Horse blood erythrocytes
were washed in PBS and resuspended at 7.10
8 cells/ml. Bacteria
were grown to late exponential phase, washed in PBS and
resuspended at 10
10 bacteria/ml at room temperature. 50 ml of the
bacterial suspension were mixed with 50 ml of erythrocytes in a
round bottom 96-well plate. Samples were centrifuged at 1506g
for 15 minutes (Rotixa/RP, Hettich, Germany) and incubated at
37uC for 90 min. Samples were resuspended in 150 ml of PBS and
centrifuged for another 15 min. 100 ml of the supernatant were
transferred to a new plate. The extent of erythrocytes lysis was
determined by reading the optical density at 595 nm [12].
Translocation of T3S effectors assay
Analysis of translocated T3S effectors was performed as
described previously with slight modifications [36]. Briefly, HeLa
cells were plated the day before the experiment at a density of 10
6
cells/100 mm-diameter dish. Cells were challenged with expo-
nentially grown bacteria resuspended in DMEM buffer containing
50 mM HEPES pH 7.4 at a final OD600=1.0. After incubation
for 10 min at 22uC followed by 30 min at 37uC, samples were
washed three times in PBS and lysed in ice-cold PBS containing
1 mM AEBSF, 0.1 mM CaCl2, 1 mM MgCl2, and 0.1% Triton
X-100. All subsequent experiments were carried out at 4uC.
Samples were scraped, transferred to an Eppendorf tube and
subjected to 20 strokes using a dounce homogeneizer. Cell debris
and bacteria were removed by two successive centrifugations for
5 min at 13 0006g. Supernatants were subjected to immunopre-
cipitation using a mix of the anti-IpaC mAb K24, J22 and N9,
each at a concentration of 3 mg/ml, or the anti-IpaB antiserum at
a 1:100 dilution, followed by protein-G sepharose. Western-blot
analysis were performed using an anti-IpaC antiserum at a
1:10,000 dilution or the anti-IpaB mAb H16 at a final
concentration of 1.5 mg/ml and revealed using the ECL reagent
(Amersham Corp.). For the A3F1 T3S reporter, samples were
subjected to immunoprecipitation using the anti-IpaA pAb and
Western blot analysis using anti-FLAG M2 mAb at 0.2 mg/ml.
Immunofluorescence analysis
Bacteria grown at exponential phase were treated with poly-L-
lysine as described above. HeLa cells were plated onto glass coverslips
at a density of 10
5 cells/24 mm624 mm coverslip and allowed to
spread for 48 h. Cells were challenged with the bacterial suspension
at a MOI of 20 bacteria/cell and cells were incubated for 15 min at
37uC. To inhibit F-actin prior to bacterial challenge, cells were
incubated in DMEM-HEPES buffer containing cytochalasin D at a
final concentration of 1 mg/ml for 30 min at 37uC. Bacteria were
allowed to adhere to cells in the same buffer for 10 min at 22uC.
Samples were washed three times with PBS to remove unbound
bacteria and the actin inhibitor and cells were incubated for the
indicated time at 37uC. The Iota two-component toxin was used as a
delivery system as previously described, with minor modifications
[32]. Briefly, cells were incubated with the Ib component at 30 nM
final concentration in EM buffer (120 mM NaCl, 6 mM KCl,
1.2 mM CaCl2,1 . 6m MM g C l 2, 6 mM NaHCO3,9m Mg l u c o s e ,
25 mM HEPES pH 7.4) for 10 min at 21uC. Ia* or IaC was then
added at 30 nM final concentration, samples were incubated for
another 10 min at 21uCa n ds h i f t e da t3 7 uC for the indicated amount
of time. Samples were fixed with PBS containing 3.7% paraformal-
dehyde for 20 minutes, and processed for immunofluorescence
staining as described previously [50]. Samples were analyzed using a
conventional fluorescence microscope using a 406objective (BH2-
RFCA; Olympus Optical Co., Ltd) or with a confocal laser scanning
microscope (Zeiss Axiophot). Actin foci were scored by microscopic
observation. The numbers are representative of at least 300 cells
scored in 3 independent experiments. For the deconvolution of
selected fields, acquisition was performed using a LEICA DMRIBe
inverted microscope equipped with a piezzo (Physik Instrumente,
GmbH & Co, Karlsruhe, Germany), using a 636objective (N.A.
1.25). Routinely, stacks of focal planes spaced by 0.2 mmw e r e
acquired and processed for PSF-based 3D deconvolution in the
Metamorph software 7.0r4 (Universal Imaging) using a fast
algorithm. Reconstructions were obtained by applying the average
function on the stacks of deconvolved images. For live cells imaging,
HeLa cells were transfected using the Fugene reagent (Boehringer-
Mannheim) and allowed to express the Src-GFP construct [27] for
16 hours prior to bacterial challenge. Samples were mounted in a
microscopic chamber on a LEICA DMRIBe inverted microcoscope
in a 37uC-temperature controlled box, connected to a Cool-Snap
HQ CCD camera (Roper’s Instruments), driven by the Metamorph
software 6.1 (Universal Imaging).
Supporting Information
Figure S1 Effects of the Src inhibitor PP2 on Shigella invasion.
(A,B) HeLa cells were challenged with bacteria for 15 min at 37uC
in the absence or the presence of 10 mM PP2. (A) Samples were
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and F-actin (green). Cells challenged with wild-type Shigella (WT);
the non-invasive mxiD mutant (mxiD) in buffer alone or in the
presence of 10 mM PP2 (+PP2). Scale bar=10 mm. (B) Actin foci
were scored microscopically. Values correspond to the average of
counts obtained for at least 300 cells in three independent
experiments. (C) HeLa cells were challenged with wild-type Shigella
for the indicated time points in the absence or the presence of
10 mM PP2. Cell lysates were prepared and analyzed by anti-
phosphotyrosine Western blotting (Materials and Methods). The
arrowhead indicates the expected migration of cortactin. PP2 leads
to inhibition of Shigella-induced actin foci and cortactin phosphor-
ylation.
Found at: doi:10.1371/journal.ppat.1000271.s001 (9.00 MB TIF)
Figure S2 Src but not Fyn increases Shigella-induced actin foci
formation in SYF cells. (A–D) Cells were challenged for 15 min at
37uC with bacteria as indicated. SYF: parental SYF cells; SYF/
Src: SYF cells transfected with Src-GFP; SYF/Fyn: SYF cells
transfected with Fyn-GFP. (A) Samples were fixed and processed
for immunofluorescence staining of bacterial LPS (red) and F-actin
(cyan). Scale bar=10 mm. (B) Actin foci were scored microscop-
ically. Values correspond to the average number of actin foci per
cell6SEM for at least 300 cells in three independent experiments.
(C,D) Representative actin foci induced by wild-type Shigella in
SYF/Src cells (C) or SYF/Fyn cells (D). GFP fluorescence is shown
in green. Scale bar=2 mm. As opposed to Src-GFP, Fyn-GFP is
not recruited at Shigella contact sites.
Found at: doi:10.1371/journal.ppat.1000271.s002 (2.02 MB TIF)
Figure S3 Immunofluorescence detection of IpaC in actin foci
induced by wild-type Shigella. Stable Src transfectants of HeLa cells
were challenged at 37uC for 10 min with the Shigella wild-type
strain M90T. Samples were fixed and processed for fluorescent
staining with rhodamine-phalloidin (actin), anti-IpaC pAb (blue),
and anti-Src mAb GD11 (Src). Merge: red, actin; blue, IpaC;
green, Src. Reconstructions of deconvolved images from focal
planes spaced by 0.2 mm. Scale bar=2 mm. Src and IpaC
localize in an inner area of actin foci.
Found at: doi:10.1371/journal.ppat.1000271.s003 (0.90 MB TIF)
Figure S4 Src recruitment occurs in Shigella mutants defective
for the T3S effectors IpaA, IpgB2, and IpgD. HeLa cells were
transfected with Src-GFP and challenged at 37uC for 15 min. with
the ipaB, ipaA, ipgB2, ipgD, and the SF126 mutant strains.
Samples were fixed and processed for anti-LPS immunofluores-
cence labeling (blue), and F-actin staining (red). Src-GFP
fluorescence is shown in green. The images correspond to
reconstructions of deconvolved images from focal planes spaced
by 0.2 mm. The ipaB mutant is defective at inducing Src
recruitment, while all other T3S mutants induce Src recruitment.
Found at: doi:10.1371/journal.ppat.1000271.s004 (6.21 MB TIF)
Figure S5 The ipaC/pC351 and ipaC/pC1myc Shigella strains
do not induce Src recruitment. (A) Stable Src transfectants of
HeLa cells were challenged at 37uC for 10 min with the Shigella
wild-type strain M90T (WT), ipaC/pC1 (C1), or ipaC/pC351
strain (C351) at an MOI=300. Samples were fixed and processed
for immunofluorescent staining of Src (green) and IpaC (red). The
arrows indicate IpaC and Src co-localization. At the high MOI
used, bacteria essentially coat the cell surface (not shown). Even at
this high MOI, the C351 construct does not induce Src
recruitment. (B) HeLa cells transfected with Src-GFP were
challenged for 10 min at 37uC with the ipaC/C1myc strain.
Samples were fixed and processed for fluorescent staining with
rhodamine-phalloidin (actin) and anti-IpaC (blue) Ab. GFP-
fluorescence is shown in green. Panels Src, actin and IpaC:
deconvolved images of a single focal plane (Materials and
Methods); IpaC+phase: overlay of the IpaC panel with the
corresponding focal plane acquired in phase contrast. When
quantified, Shigella ipaC/pC1myc bacteria did not show significant
association with Src-GFP structures (145 bacteria, n=3), whereas
47.0%612.5 (SEM) of ipaC/pC1 bacteria showed association
with Src-GFP (223 bacteria, n=3).
Found at: doi:10.1371/journal.ppat.1000271.s005 (5.96 MB TIF)
Figure S6 The IpaC last 72 carboxyterminal residues containing
the C3 insertion at residue 351 (IaC351) fused does not induce
actin reorganization. HeLa cells transfected with Src-GFP (green)
were challenged with the Iota Ib component and IaC351. Samples
were incubated for 15 min at 37uC, fixed, and processed for
fluorescent staining of F-actin (red). Scale bar=10 mm. IaC351
does not induce ruffling or the formation of actin foci (395 cells,
n=3).
Found at: doi:10.1371/journal.ppat.1000271.s006 (2.62 MB TIF)
Figure S7 Localization of fluorescently labeled Ib in actin-like
foci in HeLa cells challenged with IbIaC. HeLa cells transfected
with Src-GFP were challenged with the Iota Ib component,
fluorescently labeled as previously described [33], and IaC.
Samples were processed for fluorescent staining of F-actin. Arrows
point at IbIaC-induced actin ruffles. Scale bar=5 mm. Ib localizes
in actin-like foci that are enriched in Src-GFP.
Found at: doi:10.1371/journal.ppat.1000271.s007 (4.95 MB TIF)
Video S1 Early recruitment of Src-GFP at Shigella entry sites.
HeLa cells transfected with Src-GFP were challenged with wild-
type Shigella expressing the AfaE adhesin at 37uC. Dual acquisition
of phase contrast and GFP fluorescence images was performed
every 15 sec. Movie is shown at 8 frames/sec. Src localizes initially
at the intimate bacterial-cell contact site prior to recruitment in
bacterial-induced ruffles.
Found at: doi:10.1371/journal.ppat.1000271.s008 (1.66 MB
MOV)
Video S2 Cell contact occurs at one bacterial pole during Shigella
invasion. Phase-contrast acquisition of HeLa cells challenged with
wild-type Shigella expressing the AfaE adhesin at 37uC. Images
were acquired every 15 sec. Movie is shown at 30 frames/sec.
Found at: doi:10.1371/journal.ppat.1000271.s009 (0.74 MB
MOV)
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